Guidelines for Pharmacists in Nicotine Cessation
Including clinical guidance and recommended dosage regimes for nicotine-containing pulmonary delivery products for smoking cessation.
What did we do?
PSA is part of a consortium of peak bodies who will inform and support the design, development and delivery of evidence-based content, interventions and for this comprehensive educational program.
Why did we do it?
PSA is best placed to support the aims and objectives of the QUDTP grant activities, through strong membership engagement that provides high-quality health care and are the custodians for safe and effective medicine use for the Australian community.
Value to PSA members
This project will deliver free, patient centred education for the profession.
These guidelines are applicable to all practice settings in which pharmacists provide smoking cessation support, including non-prescription medicines.
New guidelines coming 1 October 2024.
Project impact:
Coming soon.
The development of the Guidelines for pharmacists providing smoking cessation support has been funded by the Australian Government Department of Health and Aged Care
For more information about this project, please contact Nena Nikolic and Jarrod McMaugh
